Perbedaan Charlie Hospital Semarang Tbk. dan Unilever Indonesia Tbk.: Charlie Hospital Semarang Tbk. diperdagangkan di Rp270 (kapitalisasi pasar 742 M, volume 24 jam 29,45 jt), sedangkan Unilever Indonesia Tbk. diperdagangkan di Rp1.710 (kapitalisasi pasar 66,19 T, volume 24 jam 17,49 jt). Perbedaan utamanya: Unilever Indonesia Tbk. jauh lebih besar — sekitar 89,2× kapitalisasi pasar Charlie Hospital Semarang Tbk., dan Charlie Hospital Semarang Tbk. lebih aktif diperdagangkan (29,45 jt vs 17,49 jt). Mana yang lebih baik tergantung tujuan investasimu.
| RSCH | UNVR | |
|---|---|---|
Kapitalisasi Pasar | 742 M | 66,19 T |
Volume | 29,45 jt | 17,49 jt |
Lot | 294,49 rb | 174,92 rb |
Perputaran | 8,14 M | 30,1 M |
Harga Rata-rata | 276,35 | 1.720,92 |
Nilai Transaksi | 8,14 M | 30,1 M |
Harga Ekuilibrium Indikatif | 270 | 1.710 |
Volume Ekuilibrium Indikatif | 103 | 13,43 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Selengkapnya di halaman RSCH →PT Unilever Indonesia Tbk (the Company) was established on 5 December 1933 as Levers Zeepfabrieken N.V. by deed No. 23 of Mr. A.H. van Ophuijsen, a notary in Batavia, which was approved by the Gouverneur Generaal van Nederlandsch-Indie in letter No. 14 on 16 December 1933, registered at the Raad van Justitie in Batavia under No. 302 on 22 December 1933 and published in the Javasche Courant on 9 January 1934, Supplement No. 3.
Selengkapnya di halaman UNVR →